Physicians' Academy for Cardiovascular Education

Updates in the 2019 ESC/EAS guidelines for the management of dyslipidemia

10' education - Sep. 29, 2020 - Prof. François Mach, MD - Geneva, Switzerland

Video navigation menu

  • Fundamental principles for LDL-c-lowering therapy 04:00
  • Treatment goals for LDL-c across categories of total CVD risk 06:31
  • Recommendations for pharmacological LDL-c lowering 07:32
  • Recommendations for lipid-lowering therapy in very-high-risk patients with ACS 10:35
  • Recommendations for treatment of patients with hypertriglyceridemia  13:24
  • The modern concept of lipid-lowering strategies to reduce CVD 16:44

Educational information

This lecture by prof. François Mach, MD is part of the virtual symposium "Reducing Residual Risk for Cardiovascular Disease: Is there a role for non-LDL lowering agents?" from the German Cardiac Society.


Prof. François Mach, MD is cardiologist at the Geneva University Hospital in Switzerland.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Amarin.

Watch another video in this series

Share this page with your colleagues and friends: